SCHEDULE: AIGH Capital Discloses 7.9% Stake in Biofrontera Inc.

AIGH Capital Management LLC and Orin Hirschman report a 7.9% beneficial ownership stake in Biofrontera Inc. as of December 31, 2025.

Summary

• Orin Hirschman and AIGH Capital Management LLC, along with AIGH Investment Partners, L.L.C., have jointly filed an Amendment No. 2 to Schedule 13G.
• The reporting persons beneficially own an aggregate of 915,210 shares of Biofrontera Inc. Common Stock.
• This ownership represents 7.9% of the company's outstanding common stock.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Biofrontera Inc., except for activities solely in connection with a nomination under Rule 14a-11.
• The reported beneficial ownership excludes 14,642,510 common shares that are issuable upon conversion of preferred shares and convertible notes, which are not currently convertible or exercisable due to beneficial ownership limitations.

Sentiment

Score: 5

Explanation: This is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's operational or financial performance.

Industry Context

This filing is a standard disclosure of beneficial ownership by an investment firm and its principals, indicating a significant, non-controlling stake in Biofrontera Inc. Such disclosures are common in the investment landscape and provide transparency regarding major shareholders.

Stakeholder Impact

• Shareholders: The disclosure of a significant 7.9% stake by an investment firm and its managing member provides transparency regarding a major shareholder and could be interpreted as a signal of confidence in the company, or potential for future engagement.

Key Dates

Keywords

Biofrontera Inc., AIGH Capital Management, Orin Hirschman, Beneficial Ownership, Schedule 13G, Common Stock, Investment Stake, SEC Filing